Bioretec earns breakthrough designation for spinal interbody cage

Bioretec earned the FDA’s breakthrough device designation for its RemeOs spinal interbody cage, the company said March 14.

Advertisement

RemeOs is designed to restore intervertebral height and facilitate cervical spinal fusion, according to a news release. 

With breakthrough designation Bioretec will look into accelerating development of RemeOs.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.